Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2021-12-08 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Cresco Labs won a Silver Clio Cannabis Award for a social justice documentary trailer. It discusses the award, the documentary, and related marketing campaigns. There is no financial data, no mention of financial results, no regulatory filings, no shareholder votes, no management changes, no capital or financing updates, and no legal proceedings. The document is a corporate announcement about an award and marketing initiatives, not a financial or regulatory report. Therefore, it does not fit into categories like Annual Report, Earnings Release, Regulatory Filings, or others related to financial or governance disclosures. The best fitting category is Regulatory Filings (RNS) as a general corporate announcement that does not fit other specific categories.
2021-12-08 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the opening of a new dispensary by Cresco Labs. It contains no financial statements, no regulatory filing references, no voting results, no management or board changes, no earnings data, and no detailed financial or strategic presentation. It is a corporate announcement about business expansion and operational updates. The document length is 5762 characters, which is relatively short and typical for a press release. It does not fit into categories like Annual Report, Earnings Release, or Investor Presentation. It is not a regulatory filing or certification. The content is purely an operational business update, which does not match any of the specific filing categories related to financial or governance disclosures. Therefore, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2021-12-07 English
News release - English.pdf
Regulatory Filings
2021-11-29 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a FORM 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Cresco Labs Inc. It certifies the review and fair presentation of interim financial statements and interim MD&A for the period ended September 30, 2021. The document is primarily an officer certification letter, not containing actual financial data or the interim report itself. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR). The document length is short (2978 characters), and it is a certification rather than the report itself.
2021-11-19 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Cresco Labs Inc. regarding the interim financial statements and interim MD&A for the period ended September 30, 2021. It is titled as a "FORM 52-109FV2 CERTIFICATION OF INTERIM FILINGS VENTURE ISSUER BASIC CERTIFICATE." The content focuses on the CEO's attestation about the accuracy and fair presentation of the interim filings, but it does not contain the actual financial statements or substantive financial data. It is primarily an officer certification document related to interim filings. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2993 characters), and it is a certification rather than a full report or announcement of a report publication. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-11-19 English
Interim MD&A - English.pdf
Regulatory Filings
2021-11-19 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.